Dali Zhao

Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma

Bo Zhai, Fengli Hu, Xian Jiang et al. · Molecular Cancer Therapeutics · 2014 · 283 citations

Medicine, Oncology, Pharmacology +17

Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells

Dali Zhao, Bo Zhai, Changjun He et al. · Cellular Signalling · 2014 · 138 citations · Full text

Medicine, Oncology, Pharmacology +16

2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2

Li Ma, Guangxin Li, Huaqiang Zhu et al. · Cancer Letters · 2014 · 90 citations

Medicine, Oncology, Pharmacology +14

Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells

Peng Han, Hali Li, Xian Jiang et al. · Molecular Oncology · 2017 · 70 citations · Full text

Medicine, Oncology, Pharmacology +15

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress

Bo Zhai, Fengli Hu, Haijiang Yan et al. · PLoS ONE · 2015 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16